Finanza

Horizon Therapeutics Public Limited Company: BMO Capital conferma il rating Buy

Horizon Therapeutics Public Limited Company: BMO Capital conferma il rating Buy

Horizon Therapeutics Public


FIMA2632# 2022-08-04T17:01:13+02:00

Show More